ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, today announced U.S. Urology Partners, one of the nation’s ...

ImmunityBio (IBRX) announced U.S. Urology Partners, one of the nation’s largest independent providers of urology and related specialty ...

Following the Bacillus Calmette-Guérin shortage, the first patient with bladder cancer has been dosed with recombinant ...

Cone, Co-Director of Clinical Research, Urology of Indiana, an affiliate of U.S. Urology. The Serum Institute of India, ImmunityBio’s collaboration partner, is the ...

Cone, Co-Director of Clinical Research, Urology of Indiana, an affiliate of U.S. Urology. The Serum Institute of India, ImmunityBio’s collaboration partner, is the world’s largest manufacturer ...

Reichard, MD, co-director of clinical research at Urology of Indiana, an affiliate of U.S. Urology, in the news release. 1 “rBCG represents a long overdue potential alternative but does not abrogate ...

Reichard, MD, shared his thoughts on how the EAP may have an impact on the shortage. Reichard is a urologist at Urology of Indiana, an affiliate of US Urology Partners, which recently became the first ...

Cone, Co-Director of Clinical Research, Urology of Indiana, an affiliate of U.S. Urology. The Serum Institute of India, ImmunityBio’s collaboration partner, is the world’s largest manufacturer of ...